NCT03827031
Recruiting
Not Applicable
Implementation and Impact of Multidisciplinary Medication Review in Surgery Departments on Medication Management of Elderly Patients
Centre Hospitalier Universitaire de Nīmes8 sites in 1 country297 target enrollmentJuly 18, 2022
ConditionsChronic Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Disease
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Enrollment
- 297
- Locations
- 8
- Primary Endpoint
- Change in iatrogenic drug risk in intervention groups versus control group
- Status
- Recruiting
- Last Updated
- 8 months ago
Overview
Brief Summary
The presence of a clinical pharmacist (for their pharmacological expertise) and a general practitioner (for their somatic expertise) in surgery departments would contribute to improve the management of medications in elderly patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The patient (or their representative) has given his consent and signed the consent form.
- •The patient is affiliated to a health insurance programme.
- •The patient is at least 65 years old (≥) treated by at least (≥) five medications for at least (≥) 6 months
- •The patient is available for a follow-up of 3 months.
- •The patient is hospitalized in the surgery department.
- •Patient with a Trivalle score greater than or equal to 2 (≥).
- •Patient living in a nursing home or going back home after hospitalization.
Exclusion Criteria
- •The subject is participating in another category I interventional study.
- •The subject is in an exclusion period determined by another study.
- •The subject is under safeguard of justice.
- •It is not possible to give the patient (or his/her trusted-person) informed information.
- •Palliative care
Outcomes
Primary Outcomes
Change in iatrogenic drug risk in intervention groups versus control group
Time Frame: 3 months after hospitalization
Proportion of patients transitioning from intermediate or high to low risk according to Trivalle score (a score between 0-10. A score 0-1 constitutes a low ADE risk (12%), score 2-5 represents an average risk (32%), and a score 6-10 represents a high risk (53%)
Secondary Outcomes
- Description of reason for non-transmission of multidisciplinary correspondence documents in the B2 group(Hospital discharge (maximum 30 days))
- Proportion of proposed medication modifications made by the collaborative team accepted and/or made permanent(3 months after hospital discharge)
- Time required for Multidisciplinary Medication Review in the interventional groups (B1 and B2)(Hospital discharge (maximum 30 days))
- Time required for ransmitting multidisciplinary correspondence documents in B2 group(Hospital discharge (maximum 30 days))
- Rate of patients for whom a follow-up review of proposed medication changes has been performed by the pharmacist in the B2 group(2 months post discharge)
- Mortality rate in each group(3 months after hospital discharge)
- Description of mode of diffusion of multidisciplinary correspondence documents in the B2 group(Hospital discharge (maximum 30 days))
- Rate of patients with at least one rehospitalization in each group(3 months after hospital discharge)
- patient satisfaction in all groups (A, B1, B2)(3 months after hospital discharge)
- Proportion of proposed medication modifications made by the clinical pharmacist accepted by the clinical doctor during the Multidisciplinary Medication Review in the experimental groups(Hospital discharge (maximum 30 days))
- Number of potentially inappropriate medications per patient in each group(3 months after hospital discharge)
- Number of multidisciplinary correspondence documents sent to the community acotors in B2 group(Hospital discharge (maximum 30 days))
- Number of multidisciplinary correspondence documents transmitted by community pharmacist in group B2(2 months post hospital discharge)
- Healthcare team satisfaction in interventional groups (B1, B2)(3 months after hospital discharge)
Study Sites (8)
Loading locations...
Similar Trials
Completed
Not Applicable
Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary CareAnticoagulantPharmacogeneticsCommunity Pharmacy ServicesDrug Utilization ReviewMedication Therapy ManagementNCT03154489Universidad San Jorge204
Completed
Not Applicable
Clinical Pharmacists' Intervention on Pain Management in Cancer PatientsCancerCancer PainNCT05021393Monash University Malaysia92
Completed
Not Applicable
Impact of Multidisciplinary Review of Drug Prescriptions on Patient Safety in a Residence for Dependent ElderlyGeriatricsResidence for Dependent ElderlyHealth Services for the AgedNCT02118259Centre Hospitalier Universitaire de Nīmes49
Withdrawn
Not Applicable
Measuring the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-centered Medical HomePolypharmacyNCT02077725Ohio State University
Completed
Phase 4
Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team EnvironmentHeart Failure, CongestivePulmonary Disease, Chronic ObstructivePneumoniaDiabetes Mellitus, Type 2Coronary ArteriosclerosisNCT00351676University of Alberta452